Metraipolis › archive › dc_dc75bcaa0231
The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies — Europe PMC PMID:40856900
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40856900
- DOI
- 10.1007/s12032-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:56:35.750Z
- SHA-256 of the archived text
086bdda76bfc79cf17823dae5e32257f5683af58139a0f980bf36b60286957a0- Stable URL of this page
https://metraipolis.com/documento/dc_dc75bcaa0231
How to cite
The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies — Europe PMC PMID:40856900 — Europe PMC (en), https://europepmc.org/article/MED/40856900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc75bcaa0231 (Metraipolis archive dc_dc75bcaa0231, sha256 086bdda76bfc79cf17823dae5e32257f5683af58139a0f980bf36b60286957a0)
BibTeX
@misc{dcdc75bcaa0231,
title = {The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies — Europe PMC PMID:40856900},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40856900},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc75bcaa0231; sha256 086bdda76bfc79cf17823dae5e32257f5683af58139a0f980bf36b60286957a0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40856900. Agents can read the archived copy with the MCP tool read_document.